ATE428402T1 - Opioidabgabesystem - Google Patents

Opioidabgabesystem

Info

Publication number
ATE428402T1
ATE428402T1 AT04715861T AT04715861T ATE428402T1 AT E428402 T1 ATE428402 T1 AT E428402T1 AT 04715861 T AT04715861 T AT 04715861T AT 04715861 T AT04715861 T AT 04715861T AT E428402 T1 ATE428402 T1 AT E428402T1
Authority
AT
Austria
Prior art keywords
opioid
administration
formulation
pulmonary
delivery system
Prior art date
Application number
AT04715861T
Other languages
English (en)
Inventor
Orlando Hung
Steven Shafer
Diana Pliura
Original Assignee
Ym Biosciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ym Biosciences Inc filed Critical Ym Biosciences Inc
Application granted granted Critical
Publication of ATE428402T1 publication Critical patent/ATE428402T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0078—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4468—Non condensed piperidines, e.g. piperocaine having a nitrogen directly attached in position 4, e.g. clebopride, fentanyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4748—Quinolines; Isoquinolines forming part of bridged ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurology (AREA)
  • Pulmonology (AREA)
  • Otolaryngology (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Neurosurgery (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Diaphragms For Electromechanical Transducers (AREA)
  • Paper (AREA)
  • Signal Processing For Digital Recording And Reproducing (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT04715861T 2003-02-28 2004-03-01 Opioidabgabesystem ATE428402T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US45033303P 2003-02-28 2003-02-28
PCT/CA2004/000303 WO2004075879A1 (en) 2003-02-28 2004-03-01 Opioid delivery system

Publications (1)

Publication Number Publication Date
ATE428402T1 true ATE428402T1 (de) 2009-05-15

Family

ID=32927636

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04715861T ATE428402T1 (de) 2003-02-28 2004-03-01 Opioidabgabesystem

Country Status (19)

Country Link
EP (1) EP1603533B1 (de)
JP (1) JP2006519185A (de)
KR (1) KR20050114221A (de)
CN (1) CN1780605A (de)
AT (1) ATE428402T1 (de)
AU (1) AU2004216550B2 (de)
BR (1) BRPI0408059A (de)
CA (1) CA2556629A1 (de)
CY (1) CY1109215T1 (de)
DE (1) DE602004020597D1 (de)
DK (1) DK1603533T3 (de)
ES (1) ES2325834T3 (de)
IL (1) IL177764A0 (de)
MX (1) MXPA05009179A (de)
NZ (1) NZ542005A (de)
PT (1) PT1603533E (de)
RU (1) RU2362559C2 (de)
WO (1) WO2004075879A1 (de)
ZA (1) ZA200607418B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2907121B1 (fr) * 2006-10-12 2012-05-04 Neorphys Nouveaux derives morphiniques
EP2039360A1 (de) * 2007-09-19 2009-03-25 Euro-Celtique S.A. Nicht-invasive Direktverabreichung von Opioiden ins Zentralnervensystem
GB0919893D0 (en) * 2009-11-13 2009-12-30 Biocopea Ltd Drug composition and its use in therapy
KR101298303B1 (ko) * 2010-04-27 2013-08-20 울산대학교 산학협력단 약물의 약동-약력학적 모델링을 위한 통합 분석 시스템
DE102012009617B4 (de) * 2012-05-15 2020-03-26 Drägerwerk AG & Co. KGaA Datenverarbeitungseinrichtung für eine Anästhesievorrichtung

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8900267D0 (en) * 1989-01-06 1989-03-08 Riker Laboratories Inc Narcotic analgesic formulations and apparatus containing same
US5451408A (en) * 1994-03-23 1995-09-19 Liposome Pain Management, Ltd. Pain management with liposome-encapsulated analgesic drugs
EP0759744B1 (de) * 1994-05-13 2001-10-17 Aradigm Corporation Ein narkotikum enthaltende aerosolformulierung
GB9415810D0 (en) * 1994-08-04 1994-09-28 Jerrow Mohammad A Z Composition
GB9606188D0 (en) * 1996-03-23 1996-05-29 Danbiosyst Uk Pollysaccharide microspheres for the pulmonary delivery of drugs
JP2002532405A (ja) * 1998-12-11 2002-10-02 ファルマヘミー ベー．フェー． オピオイド吸入製剤
US7766013B2 (en) * 2001-06-05 2010-08-03 Alexza Pharmaceuticals, Inc. Aerosol generating method and device
CA2446904A1 (en) * 2001-05-24 2003-04-03 Alexza Pharmaceuticals, Inc. Delivery of drug esters through an inhalation route

Also Published As

Publication number Publication date
MXPA05009179A (es) 2006-03-08
BRPI0408059A (pt) 2006-02-14
NZ542005A (en) 2009-05-31
RU2362559C2 (ru) 2009-07-27
DE602004020597D1 (de) 2009-05-28
WO2004075879A1 (en) 2004-09-10
ES2325834T3 (es) 2009-09-21
AU2004216550A1 (en) 2004-09-10
RU2005130166A (ru) 2006-06-10
PT1603533E (pt) 2009-07-23
CY1109215T1 (el) 2014-07-02
KR20050114221A (ko) 2005-12-05
IL177764A0 (en) 2007-03-08
DK1603533T3 (da) 2009-08-17
AU2004216550B2 (en) 2010-06-03
EP1603533B1 (de) 2009-04-15
CA2556629A1 (en) 2004-09-10
EP1603533A1 (de) 2005-12-14
JP2006519185A (ja) 2006-08-24
HK1084341A1 (en) 2006-07-28
CN1780605A (zh) 2006-05-31
ZA200607418B (en) 2008-01-30

Similar Documents

Publication Publication Date Title
SE0102276D0 (sv) Device and method for the administration of a medicament
SE0201669D0 (sv) New formulation and use thereof
DE60030844D1 (de) Kombinationen von formoterol und tiotropium-salz
TW200505881A (en) Tri(cyclo) substituted amide compounds
IT1317846B1 (it) Formulazioni contenenti un farmaco anticolinergico per il trattamentodella broncopneumopatia cronica ostruttiva.
EP1638639A4 (de) Arzneimittelabgabevorrichtung und verfahren
CY1107850T1 (el) Παραγωγα θειαδιαζολυλοπιπεραζiνης mε χρησιμοτητα στην αποτροπη ή στην αγωγη εναντι tου αλγους
NO20062504L (no) Sammensetninger og doseringsformer for forbedret absorpsjon
UA88464C2 (ru) Способ дермального введения метадоновой композиции с обеспечением системного действия
FI20012462A7 (fi) Farmaseuttisia formulaatioita ja menetelmiä käsittäen intranasaalista morfiinia
NO20043871L (no) Legemiddelformuleringer med kontrollert frigjoring som inneholder et baererpeptid
EP1781256A4 (de) Phospholipid-gel-zusammensetzungen für die arzneiabgabe und verfahren zur behandlung von erkrankungen damit
NO20065904L (no) Terapeutiske forbindelser
DK1383752T3 (da) Deutererede 3-piperidinopropiophenoner samt lægemidler indeholdende disse forbindelser
CY1109215T1 (el) Συστημα χορηγησης οπιοειδους
EP0877609A4 (de) Formulierung zur verabreichung über die atemwege
BG104797A (en) Use of dexmedetomi dine for sedative effect in patients in an intensive care unit
CN106102823A (zh) 用于基于使用者吸入控制治疗剂的离子电渗递送的系统和方法
ATE398441T1 (de) Octenidinhaltige lutschtabletten gegen entzündliche erkrankungen des mund- und rachenraums
BRPI0412430A (pt) polipeptìdeo agonista do receptor de zot e zonulina
MXPA06003122A (es) Composiciones farmaceuticas y procedimientos que comprenden combinaciones de derivados de 2-alquiliden-19-nor-vitamina d y un agonista/antagonista de estrogenos.
TW200500070A (en) Method of improved diuresis in individuals with impaired renal function
DE60302431D1 (de) Methode zur behandlung eines analgesiebedürftigen patienten
GEP201606538B (en) Preoperative treatment of post operative pain
EA200802159A1 (ru) Введение агониста-антагониста пациентам с опиоидной зависимостью

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1603533

Country of ref document: EP

REN Ceased due to non-payment of the annual fee